| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.67 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |